CYP2D6 GENOTYPE AND POSSIBLE SUSCEPTIBILITY TO THE NEUROLEPTIC MALIGNANT SYNDROME

被引:12
作者
IWAHASHI, K
机构
关键词
D O I
10.1016/0006-3223(94)90094-9
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
引用
收藏
页码:781 / 782
页数:2
相关论文
共 5 条
[1]
BARBEAU A, 1985, LANCET, V2, P1213
[2]
CHANGES IN BODY-TEMPERATURE AFTER ADMINISTRATION OF AMINO-ACIDS, PEPTIDES, DOPAMINE, NEUROLEPTICS AND RELATED AGENTS [J].
CLARK, WG .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1979, 3 (04) :179-231
[3]
LEVENSON JL, 1985, AM J PSYCHIAT, V142, P1137
[4]
NEUROLEPTIC MALIGNANT SYNDROME-LIKE STATE FOLLOWING A WITHDRAWAL OF ANTI-PARKINSONIAN DRUGS [J].
TORU, M ;
MATSUDA, O ;
MAKIGUCHI, K ;
SUGANO, K .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1981, 169 (05) :324-327
[5]
A NOVEL CYTOCHROME-P-450IID6 MUTANT-GENE ASSOCIATED WITH PARKINSONS-DISEASE [J].
TSUNEOKA, Y ;
MATSUO, Y ;
IWAHASHI, K ;
TAKEUCHI, H ;
ICHIKAWA, Y .
JOURNAL OF BIOCHEMISTRY, 1993, 114 (02) :263-266